More than half of cancer patients receiving a single dose of the Pfizer COVID-19 vaccine may be left with little protection against the virus, according to a new preprint from researchers at the Francis Crick Institute and ...
Mar 11, 2021
0
2
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. ...
Mar 10, 2021
0
12
Approximately 15-to-30 percent of patients with metastatic breast cancer have brain metastasis (BM), with basal-like breast cancer (BLBC) metastasizing to the brain most frequently. The prognosis for BLBC-BM patients is poor, ...
Mar 5, 2021
0
42
Researchers from Dana-Farber Cancer Institute, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research (AACR) are releasing recommendations designed to address the under-representation ...
Feb 18, 2021
0
1
Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...
Feb 10, 2021
0
141
Emergency heart attack treatment is effective in patients with cancer, yet many do not receive it. That's the finding of a study published on World Cancer Day in European Heart Journal—Acute Cardiovascular Care, a journal ...
Feb 4, 2021
0
2
Patients with blood cancers such as leukemia vary in their immune response to COVID-19 and can struggle to clear infection for very many weeks, according to new research published in Cancer Cell. By contrast, most patients ...
Jan 6, 2021
0
40
In a new study, researchers at Uppsala University have been able to show differences in how rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic ...
Dec 11, 2020
0
3
White blood cells are part of many immune system responses in the human body. New research shows that a specific type of those cells may cause brain cancer tissues to die—but that's not good news, according to researchers ...
Dec 7, 2020
0
37
Each cancer patient's tumors have cells that look and act differently, making it difficult for scientists to determine treatments based on tumors grown from generic cell cultures in the lab.
Oct 29, 2020
0
8
